MarketCapExport financials
The Estée Lauder Companies (EL)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
The Estée Lauder Companies Balance Sheet 2026-2008 | EL
Brief overview of The Estée Lauder Companies 's financial position
The review uses the five latest available annual reports between 2015 and 2019.
Total assets increased by +59.7%, from $8.2 billion to $13.2 billion. A CAGR near 12.4% points to substantial expansion.
Liability growth of +90.7% exceeded asset growth of +59.7%, increasing reliance on outside funding.
Shareholders' equity accounts for 33.3% of assets, previously 44.2%. Dependence on liabilities is moderate.
Net debt is $425 million, or 0.1x of equity. This is a conservative debt position.
The cash reserve occupies 22.7% of the balance sheet, previously 12.4%. It is one marker of short-term resilience.
Retained earnings stand at $10 billion; the five-period change was +42.5%. This reflects accumulated business performance.
Overall picture
The Estée Lauder Companies 's balance sheet is broadly resilient, though selected areas require monitoring. The balance between assets, equity and liabilities remains the key issue.
Annual Balance Sheet The Estée Lauder Companies
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
3.7 B | 4.8 B | 4.23 B | 3.44 B | 1.55 B | 958 M | 267 M | 425 M | 1.19 B | 2.27 B | 1.33 B | 616 M | -286 M | -151 M | -59.6 M | -34.9 M | 84.3 M | - | - |
Long Term Debt |
6.8 B | 7.31 B | 7.27 B | 7.12 B | 5.14 B | 5.54 B | 4.91 B | 2.9 B | 3.36 B | 3.38 B | 1.91 B | 1.61 B | 1.32 B | 1.33 B | 1.07 B | 1.08 B | 1.2 B | - | - |
Long Term Debt Current |
399 M | 406 M | 354 M | 357 M | 365 M | 379 M | 375 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
9.72 B | 10.6 B | 10.7 B | 10.8 B | 8.66 B | 9.72 B | 8.64 B | 4.14 B | 4.55 B | 4.34 B | 2.96 B | 2.45 B | 1.94 B | 1.91 B | 1.72 B | 1.68 B | 1.8 B | - | - |
Total Current Liabilities |
6.23 B | 5.44 B | 5.7 B | 6.24 B | 5.82 B | 5.3 B | 5.18 B | 4.6 B | 3.31 B | 2.82 B | 2.68 B | 2.14 B | 2.06 B | 1.93 B | 2.13 B | 1.94 B | 1.57 B | - | - |
Total Liabilities |
- | - | - | - | - | - | - | 8.74 B | 7.86 B | 7.17 B | 5.64 B | 4.58 B | 4 B | 3.84 B | 3.85 B | 3.63 B | - | - | - |
Deferred Revenue |
282 M | 314 M | 327 M | 323 M | 312 M | 322 M | 222 M | 314 M | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
11.3 B | 11.7 B | 13.4 B | 14 B | 13.9 B | 12.2 B | 10.1 B | 9.98 B | 9.04 B | 8.45 B | 7.69 B | 7 B | 6.27 B | 5.36 B | 4.76 B | 4.12 B | 3.56 B | - | - |
Total Assets |
19.8 B | 19.9 B | 21.7 B | 23.4 B | 20.9 B | 22 B | 17.8 B | 13.2 B | 12.6 B | 11.6 B | 9.22 B | 8.24 B | 7.87 B | 7.15 B | 6.59 B | 6.27 B | 5.34 B | 5.18 B | - |
Cash and Cash Equivalents |
3.5 B | 2.92 B | 3.4 B | 4.03 B | 3.96 B | 4.96 B | 5.02 B | 2.99 B | 2.18 B | 1.14 B | 914 M | 1.02 B | 1.63 B | 1.5 B | 1.35 B | 1.25 B | 1.12 B | 864 M | 402 M |
Book Value |
19.8 B | 19.9 B | 21.7 B | 23.4 B | 20.9 B | 22 B | 17.8 B | 4.41 B | 4.71 B | 4.4 B | 3.59 B | 3.65 B | 3.87 B | 3.3 B | 2.75 B | 2.65 B | 5.34 B | 5.18 B | - |
Total Shareholders Equity |
3.81 B | 3.86 B | 5.31 B | 5.58 B | 5.59 B | 6.09 B | 3.96 B | 4.39 B | 4.69 B | 4.38 B | 3.57 B | 3.64 B | 3.85 B | 3.29 B | 2.73 B | 2.63 B | 1.95 B | 1.66 B | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Balance Sheet The Estée Lauder Companies
| 2027-Q1 | 2026-Q4 | 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.56 B | 1.54 B | 1.59 B | 1.66 B | 1.68 B | 7.32 B | 1.68 B | 1.71 B | 7.3 B | 7.28 B | 7.31 B | 1.7 B | 7.26 B | 6.64 B | 7.09 B | 1.76 B | 5.13 B | 5.11 B | 5.11 B | 5.14 B | 5.19 B | 5.26 B | 5.27 B | 5.54 B | 5.54 B | 4.91 B | 4.91 B | 4.91 B | 4.91 B | 4.66 B | 2.9 B | 2.9 B | 2.9 B | 3.37 B | 3.36 B | 3.36 B | 3.36 B | 3.37 B | 3.38 B | 3.38 B | 3.38 B | 1.89 B | 1.91 B | 1.91 B | 1.91 B | 1.61 B | 1.61 B | 1.6 B | 1.61 B | 1.32 B | 1.32 B | 1.32 B | 1.32 B | 1.32 B | 1.32 B | 1.33 B | 1.33 B | 1.33 B | 1.33 B | 1.07 B | 1.07 B | 1.07 B | 1.07 B | 1.08 B | 1.08 B |
Total Non Current Liabilities |
9.67 B | 9.72 B | 9.76 B | 10.3 B | 10.4 B | 10.3 B | 10.6 B | 10.6 B | 10.6 B | 10.6 B | 10.7 B | 10.1 B | 10.7 B | 10.1 B | 10.6 B | 8.36 B | 8.32 B | 8.36 B | 8.39 B | 8.66 B | 8.89 B | 9.22 B | 9.3 B | 9.72 B | 9.72 B | 8.72 B | 8.68 B | 8.64 B | 8.64 B | 8.38 B | 6.28 B | 4.14 B | 4.14 B | 4.57 B | 4.55 B | 4.55 B | 4.55 B | 4.61 B | 4.31 B | 4.34 B | 4.34 B | 2.95 B | 2.96 B | 2.96 B | 2.96 B | 2.49 B | 2.47 B | 2.44 B | 2.45 B | 1.98 B | 1.93 B | 1.94 B | 1.94 B | 1.92 B | 1.92 B | 1.91 B | 1.91 B | 1.99 B | 1.99 B | 1.72 B | 1.72 B | 1.68 B | 1.67 B | 1.68 B | 1.68 B |
Total Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.74 B | 8.31 B | 8.34 B | 8.11 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
319 M | 282 M | 294 M | 327 M | 332 M | 327 M | 276 M | 338 M | 276 M | 338 M | 338 M | 370 M | 306 M | 370 M | 336 M | 344 M | 306 M | 344 M | 313 M | 312 M | 313 M | 377 M | 379 M | 322 M | 322 M | 365 M | 353 M | 222 M | 222 M | 378 M | 345 M | 314 M | 314 M | 425 M | 371 M | 33 M | 33 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
11.4 B | 11.3 B | 11.6 B | 11.6 B | 11.6 B | 11.6 B | 12.3 B | 12.3 B | 12.3 B | 12.3 B | 13 B | 13.9 B | 14 B | 13.9 B | 13.8 B | 14.3 B | 14.3 B | 14.3 B | 14.2 B | 13.9 B | 14.1 B | 13.7 B | 12.9 B | 12.2 B | 12.2 B | 11.2 B | 10.5 B | 10.1 B | 10.1 B | 10.8 B | 10.4 B | 9.98 B | 9.98 B | 9.59 B | 9.17 B | 9.04 B | 9.04 B | 8.73 B | 8.75 B | 8.45 B | 8.45 B | 8.18 B | 7.88 B | 7.69 B | 7.69 B | 7.56 B | 7.22 B | 7 B | 7 B | 6.76 B | 6.42 B | 6.27 B | 6.27 B | 5.95 B | 5.59 B | 5.36 B | 5.36 B | 5.23 B | 5.06 B | 4.76 B | 4.76 B | 4.58 B | 4.4 B | 4.11 B | 4.12 B |
Total Assets |
20 B | 19.8 B | 19.7 B | 19.6 B | 19.3 B | 19.6 B | 19.9 B | 19.8 B | 19.9 B | 19.8 B | 21.3 B | 23.3 B | 22.7 B | 23.3 B | 22.6 B | 20.7 B | 22.7 B | 20.7 B | 20 B | 20.9 B | 21.4 B | 22.1 B | 21.6 B | 22 B | 22 B | 19.6 B | 17.9 B | 17.8 B | 17.8 B | 17.9 B | 15.4 B | 13.2 B | 13.2 B | 12.7 B | 12.5 B | 12.6 B | 12.6 B | 12.6 B | 12.2 B | 11.6 B | 11.6 B | 11.2 B | 9.35 B | 9.22 B | 9.22 B | 8.58 B | 8.43 B | 8.23 B | 8.24 B | 7.86 B | 7.66 B | 7.86 B | 7.87 B | 7.84 B | 7.52 B | 7.15 B | 7.15 B | 7.17 B | 7.01 B | 6.59 B | 6.59 B | 6.34 B | 6.14 B | 6.27 B | 6.27 B |
Cash and Cash Equivalents |
3.2 B | 3.5 B | 3.13 B | 3.08 B | 2.22 B | 3.08 B | 2.63 B | 2.59 B | 2.63 B | 2.59 B | 2.35 B | 3.94 B | 3.7 B | 3.94 B | 3.09 B | 3.72 B | 5.53 B | 3.72 B | 2.94 B | 3.96 B | 3.84 B | 4.6 B | 4 B | 4.96 B | 4.96 B | 5.54 B | 4.27 B | 5.54 B | 4.27 B | 3.6 B | 2.26 B | 3.6 B | 2.26 B | 1.88 B | 1.44 B | 2.18 B | 2.14 B | 2.1 B | 1.44 B | 1.14 B | 1.14 B | 1.26 B | 664 M | 1.26 B | 664 M | 868 M | 408 M | 868 M | 408 M | 1.24 B | 1.4 B | 1.24 B | 1.4 B | 1.75 B | 1.32 B | 1.75 B | 1.32 B | 1.32 B | 1.05 B | 1.32 B | 1.05 B | 999 M | 720 M | 999 M | 720 M |
Book Value |
20 B | 19.8 B | 19.7 B | 19.6 B | 19.3 B | - | 19.9 B | 19.8 B | - | - | - | 23.3 B | - | - | - | 20.7 B | - | 20.7 B | 20 B | 20.9 B | 21.4 B | 22.1 B | 21.6 B | 22 B | 22 B | 19.6 B | 17.9 B | 17.8 B | 17.8 B | 17.9 B | 15.4 B | 4.41 B | 4.84 B | 4.33 B | 4.43 B | 12.6 B | 12.6 B | 12.6 B | 12.2 B | 11.6 B | 11.6 B | 11.2 B | 9.35 B | 9.22 B | 9.22 B | 8.58 B | 8.43 B | 8.23 B | 8.24 B | 7.86 B | 7.66 B | 7.86 B | 7.87 B | 7.84 B | 7.52 B | 7.15 B | 7.15 B | 7.17 B | 7.01 B | 6.59 B | 6.59 B | 6.34 B | 6.14 B | 6.27 B | 6.27 B |
Total Shareholders Equity |
4.04 B | 3.81 B | 3.99 B | 4.03 B | 3.89 B | 4.03 B | 4.34 B | 4.17 B | 4.34 B | 4.17 B | 5.08 B | 5.71 B | 5.74 B | 5.71 B | 5.34 B | 5.9 B | 5.88 B | 5.9 B | 5.52 B | 5.59 B | 6.19 B | 6.25 B | 6.12 B | 6.06 B | 6.06 B | 5.42 B | 4.45 B | 3.94 B | 3.94 B | 4.57 B | 4.53 B | 4.39 B | 4.39 B | 4.31 B | 4.41 B | 4.69 B | 4.69 B | 4.56 B | 4.73 B | 4.38 B | 4.38 B | 3.79 B | 3.66 B | 3.57 B | 3.57 B | 3.6 B | 3.49 B | 3.64 B | 3.64 B | 3.82 B | 3.78 B | 3.85 B | 3.85 B | 3.87 B | 3.6 B | 3.29 B | 3.29 B | 3.11 B | 3.03 B | 2.73 B | 2.73 B | 2.63 B | 2.48 B | 2.63 B | 2.63 B |
Quarterly performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of The Estée Lauder Companies , providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Household products
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
The Clorox Company
CLX
|
$ 106.6 | 1.01 % | $ 12.9 B |  USA |
 |
Unilever PLC
UL
|
$ 66.48 | -0.2 % | $ 145 B |  Britain |
 |
Colgate-Palmolive Company
CL
|
$ 98.06 | 0.12 % | $ 79.3 B | USA |
 |
The Procter & Gamble Company
PG
|
$ 168.81 | 0.29 % | $ 394 B | USA |
 |
United-Guardian
UG
|
$ 9.01 | 1.81 % | $ 41.4 M | USA |
 |
USANA Health Sciences
USNA
|
$ 13.1 | -5.42 % | $ 243 M | USA |
 |
Revlon
REV
|
- | -4.41 % | $ 212 M | USA |
 |
Church & Dwight Co.
CHD
|
$ 111.77 | 0.41 % | $ 27.1 B | USA |
 |
Kimberly-Clark Corporation
KMB
|
$ 110.78 | -1.03 % | $ 36.8 B | USA |
 |
Hims & Hers Health
HIMS
|
$ 19.1 | -16.76 % | $ 4.3 B | USA |
 |
Coty
COTY
|
$ 4.34 | 2.73 % | $ 3.81 B | USA |
 |
e.l.f. Beauty
ELF
|
$ 118.5 | -0.71 % | $ 6.9 B | USA |
 |
Dogness (International) Corporation
DOGZ
|
$ 0.44 | -1.36 % | $ 7.84 M |  China |
 |
Helen of Troy Limited
HELE
|
$ 38.19 | 2.28 % | $ 878 M |  Bermuda |
 |
Newell Brands
NWL
|
$ 5.94 | 0.76 % | $ 2.48 B | USA |
 |
Acme United Corporation
ACU
|
$ 70.35 | 1.6 % | $ 266 M | USA |
 |
Edgewell Personal Care Company
EPC
|
$ 29.61 | 0.25 % | $ 1.41 B | USA |
 |
LifeVantage Corporation
LFVN
|
$ 4.64 | -12.29 % | $ 58.2 M | USA |
 |
Mannatech, Incorporated
MTEX
|
$ 8.62 | -3.69 % | $ 16.4 M | USA |
 |
Inter Parfums
IPAR
|
$ 135.62 | -0.4 % | $ 4.35 B | USA |
 |
Nature's Sunshine Products
NATR
|
$ 10.89 | -1.23 % | $ 196 M | USA |
 |
Nu Skin Enterprises
NUS
|
$ 4.04 | -5.61 % | $ 199 M | USA |
 |
Natura &Co Holding S.A.
NTCO
|
- | - | $ 9.02 B | - |
 |
Spectrum Brands Holdings
SPB
|
$ 88.66 | -0.75 % | $ 2.28 B | USA |